NEW DELHI: In order to ensure early availability of its Covid-19 vaccine once approved, the Pune-based Serum Institute of India (SII) has already manufactured 40 million doses of the candidate developed by the University of Oxford and AstraZeneca , under the category ‘at risk’ manufacturing and warehousing license from the …
Read More »Serum Institute prepares 40 million doses of Covid vaccine under “at risk” manufacturing and storage license | India News
